ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于回购公司股份的进展公告 | 2025-09-02 | Chinese | |
| 2025年半年度报告摘要 | 2025-08-21 | Chinese | |
| 信息披露暂缓与豁免管理制度（2025年8月） | 2025-08-21 | Chinese | |
| 对外投资管理制度（2025年8月） | 2025-08-21 | Chinese | |
| 董事、高级管理人员离职管理制度（2025年8月） | 2025-08-21 | Chinese | |
| 关于2025年半年度计提资产减值损失和信用减值损失的公告 | 2025-08-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44581125 | 关于回购公司股份的进展公告 | 2025-09-02 | Chinese | ||
| 44581108 | 2025年半年度报告摘要 | 2025-08-21 | Chinese | ||
| 44581097 | 信息披露暂缓与豁免管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44581085 | 对外投资管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44581075 | 董事、高级管理人员离职管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44581068 | 关于2025年半年度计提资产减值损失和信用减值损失的公告 | 2025-08-21 | Chinese | ||
| 44581054 | 2025年半年度报告 | 2025-08-21 | Chinese | ||
| 44580973 | 董事会决议公告 | 2025-08-21 | Chinese | ||
| 44580966 | 股东会议事规则（2025年8月） | 2025-08-21 | Chinese | ||
| 44580951 | 董事、高级管理人员薪酬管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580944 | 关于放弃优先购买权暨关联交易的公告 | 2025-08-21 | Chinese | ||
| 44580935 | 独立董事专门会议工作细则（2025年8月） | 2025-08-21 | Chinese | ||
| 44580926 | 投资者关系管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580920 | 募集资金管理办法（2025年8月） | 2025-08-21 | Chinese | ||
| 44580904 | 会计师事务所选聘制度（2025年8月） | 2025-08-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.